(2-benzylpiperidin-1-yl)(4-(2'-methyl-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone | 1476719-63-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (2-benzylpiperidin-1-yl)(4-(2'-methyl-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone
• 英文别名: (2-Benzylpiperidin-1-yl)-[4-[4-(2-methylphenyl)phenyl]triazol-1-yl]methanone
• CAS: 1476719-63-7
• 化学式: C₂₈H₂₈N₄O
• 分子量: 436.557
• InChiKey: IQAKBCIMCLFJQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  33
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  51
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (2-benzylpiperidin-1-yl)(4-(4-bromophenyl)-1H-1,2,3-triazol-1-yl)methanone 、 2-甲基苯硼酸 在 四(三苯基膦)钯 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 2.0h， 以28%的产率得到(2-benzylpiperidin-1-yl)(4-(2'-methyl-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone
  参考文献：
  名称：

  Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid Biosynthesis

  摘要：

  We have previously shown that 1,2,3-triazole ureas (1,2,3-TUs) act as versatile class of irreversible serine hydrolase inhibitors that can be tuned to create selective probes for diverse members of this large enzyme class, including diacylglycerol lipase-beta (DAGL beta), a principal biosynthetic enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG). Here, we provide a detailed account of the discovery, synthesis, and structure-activity relationship (SAR) of (2-substituted)-piperidyl-1,2,3-TUs that selectively inactivate DAGL beta in living systems. Key to success was the use of activity-based protein profiling (ABPP) with broad-spectrum and tailored activity-based probes to guide our medicinal chemistry efforts. We also describe an expanded repertoire of DAGL-tailored activity-based probes that includes biotinylated and alkyne agents for enzyme enrichment coupled with mass spectrometry-based proteomics and assessment of proteome-wide selectivity. Our findings highlight the broad utility of 1,2,3-TUs for serine hydrolase inhibitor development and their application to create selective probes of endocannabinoid biosynthetic pathways.

  DOI：

  10.1021/jm400898x

文献信息

• N1- and N2-CARBAMOYL-1,2,3-TRIAZOLE SERINE HYDROLASE INHIBITORS AND METHODS
  申请人：Cravatt Benjamin

  公开号：US20140018318A1

  公开（公告）日：2014-01-16

  The present invention provides inhibitors of a wide variety of serine hydrolase enzymes. The inhibitors of the present invention are N1- and N2-carbamoyl-1,2,3-triazole compounds such as those of Formula (I): in which N1, N2, and N3 are the nitrogen atoms at positions 1, 2, and 3, respectively, of the triazole ring, and R 4 , R 5 , R 6 and R 7 in Formula (I) are as described herein. Methods of inhibiting serine hydrolase enzymes and methods of preparing carbamoyl-1,2,3-triazole compounds also are described.

  本发明提供了一种广泛的丝氨酸水解酶酶抑制剂。本发明的抑制剂是N1-和N2-氨基甲酰基-1,2,3-三唑化合物，例如公式（I）中的化合物：其中N1、N2和N3是三唑环的1、2和3位置的氮原子，公式（I）中的R4、R5、R6和R7如本文所述。还描述了抑制丝氨酸水解酶的方法和制备氨基甲酰基-1,2,3-三唑化合物的方法。
• US9108930B2
  申请人：——

  公开号：US9108930B2

  公开（公告）日：2015-08-18
• Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid Biosynthesis
  作者：Ku-Lung Hsu、Katsunori Tsuboi、Landon R. Whitby、Anna E. Speers、Holly Pugh、Jordon Inloes、Benjamin F. Cravatt

  DOI：10.1021/jm400898x

  日期：2013.11.14

  We have previously shown that 1,2,3-triazole ureas (1,2,3-TUs) act as versatile class of irreversible serine hydrolase inhibitors that can be tuned to create selective probes for diverse members of this large enzyme class, including diacylglycerol lipase-beta (DAGL beta), a principal biosynthetic enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG). Here, we provide a detailed account of the discovery, synthesis, and structure-activity relationship (SAR) of (2-substituted)-piperidyl-1,2,3-TUs that selectively inactivate DAGL beta in living systems. Key to success was the use of activity-based protein profiling (ABPP) with broad-spectrum and tailored activity-based probes to guide our medicinal chemistry efforts. We also describe an expanded repertoire of DAGL-tailored activity-based probes that includes biotinylated and alkyne agents for enzyme enrichment coupled with mass spectrometry-based proteomics and assessment of proteome-wide selectivity. Our findings highlight the broad utility of 1,2,3-TUs for serine hydrolase inhibitor development and their application to create selective probes of endocannabinoid biosynthetic pathways.